Windtree Therapeutics Stock Story
| WINT Stock | USD 5.68 0.23 4.22% |
Slightly above 75 percent of all Windtree Therapeutics' private investors are curious in acquiring. The analysis of the overall investor sentiment regarding Windtree Therapeutics suggests that a large number of traders are confidant. Windtree Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Windtree Therapeutics. The current market sentiment, together with Windtree Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Windtree Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Windtree Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Windtree daily returns and investor perception about the current price of Windtree Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Windtree |
Requested story not found. it has been either deleted or moved. View all stories for Windtree Therapeutics.
Windtree Therapeutics Latest Timeline
Windtree Therapeutics is listed for 5.68. The company currently holds 16.83 M in liabilities with Debt to Equity (D/E) ratio of 0.95, which is about average as compared to similar companies. Windtree Therapeutics has a current ratio of 2.42, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Windtree Therapeutics until it has trouble settling it off, either with new capital or with free cash flow. So, Windtree Therapeutics' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Windtree Therapeutics sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Windtree to invest in growth at high rates of return. When we think about Windtree Therapeutics' use of debt, we should always consider it together with cash and equity.Check out Windtree Therapeutics Hype Analysis, Windtree Therapeutics Correlation and Windtree Therapeutics Performance. For more information on how to buy Windtree Stock please use our How to Invest in Windtree Therapeutics guide.You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Complementary Tools for Windtree Stock analysis
When running Windtree Therapeutics' price analysis, check to measure Windtree Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Windtree Therapeutics is operating at the current time. Most of Windtree Therapeutics' value examination focuses on studying past and present price action to predict the probability of Windtree Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Windtree Therapeutics' price. Additionally, you may evaluate how the addition of Windtree Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume |
Is Windtree Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Windtree Therapeutics. If investors know Windtree will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Windtree Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (94.32) | Quarterly Revenue Growth (1.00) | Return On Assets (0.30) | Return On Equity (3.03) |
The market value of Windtree Therapeutics is measured differently than its book value, which is the value of Windtree that is recorded on the company's balance sheet. Investors also form their own opinion of Windtree Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Windtree Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Windtree Therapeutics' market value can be influenced by many factors that don't directly affect Windtree Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Windtree Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Windtree Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Windtree Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.